Kenneth R. Deans Jr.
Carolina del Sur
Kenneth R. Deans Jr. es colaborador de The American Quorum. Con más de 30 años de experiencia en puestos de liderazgo en los sectores de la salud, la tecnología y la educación, aporta una perspectiva independiente y basada en su amplia experiencia a los temas que marcan el rumbo de Estados Unidos.
Tecnología
Netflix Adds 2.4 Million Subscribers, Reversing Losses as $6.99 Ad Tier Nears Launch
Salud
FDA and CDC Expand Omicron-Targeted COVID Boosters to Children as Young as 5
Tecnología
Meta Unveils $1,499 Quest Pro With Full-Color Mixed Reality, Eye Tracking and Microsoft Work Tools
Salud
Flu Activity Starts Rising Early as CDC Finds 2.5% Test Positivity and Influenza A Dominates U.S. Surveillance
Tecnología
Musk Revives $44 Billion Twitter Deal at $54.20 a Share as Delaware Court Pauses Trial Until October 28
Salud
FDA Approves Relyvrio for ALS After 137-Patient Trial and Divided Review, Adding First New U.S. Treatment Since 2017
Tecnología
Google Will Shut Down Stadia in January and Refund Hardware and Games After Cloud Service Misses User Targets
Salud
Biden Says ‘Pandemic Is Over’ as Federal COVID Emergency, 400 Daily Deaths and Fall Booster Campaign Continue
Tecnología
Nvidia Unveils RTX 40 Series With $1,599 Flagship and DLSS 3 AI Frame Generation on New Ada Lovelace Architecture
Salud
U.S. Confirms Circulating Vaccine-Derived Poliovirus in New York as Wastewater Evidence Shows Community Transmission
Tecnología
Ethereum Completes ‘Merge,’ Cutting Network Energy Use About 99.95% as Proof-of-Stake Replaces Mining
Salud
Updated COVID-19 Boosters Begin U.S. Rollout, Targeting BA.4 and BA.5 as CDC Replaces Prior Booster Guidance
Tecnología
Apple Unveils iPhone 14 Lineup With Satellite SOS, 48-Megapixel Pro Camera and U.S. Shift to eSIM
Salud
FDA Authorizes BA.4/BA.5 Bivalent COVID-19 Boosters; CDC Recommends Updated Shots for Ages 12 and Older
Tecnología
U.S. Imposes China Export Licenses on Nvidia A100 and H100 AI Chips, Putting $400 Million in Quarterly Sales at Risk
Salud
Pfizer and Moderna Seek FDA Clearance for BA.4/BA.5 Bivalent COVID-19 Boosters Ahead of Fall Campaign
Tecnología
Twitter Whistleblower Alleges ‘Egregious’ Security Failures and Misleading Statements to Regulators
423 stories